5 Key Takeaways

• 1

  Laboratories are prioritizing modernization decisions, focusing on careful implementation to maintain quality amid workforce constraints and rising case complexity.

• 2

  The integration of AI and data-driven tools is crucial for enhancing diagnostic capabilities, with pathologists emphasizing the need for reliable data synthesis.

• 3

  Investment priorities for 2026 reflect a shift towards sustainable capabilities, with a strong focus on workforce evolution and training as key bottlenecks.

• 4

  Pathologists express grounded optimism about cumulative progress in digital and AI-enabled approaches, highlighting practical benefits in decision support.

• 5

  The increasing complexity of molecular diagnostics necessitates education reform to prepare future pathologists for integrated data and evolving workflows.